Wisconsin researchers report developing a biodefense cocktail to boost a body's response against the common characteristics of viruses and bacteria.
The scientists at the Medical College of Wisconsin in Milwaukee -- in collaboration with a national team -- say their biodefense cocktail is expected to be deployed to U.S. troops within the next five years.
Using a nasal spray, the cocktail of drugs will trigger immune activation in each person's respiratory and gastrointestinal tracts, the most likely routes of attack.
Dr. Harry Whelan, professor of neurology and senior author, said, "This will revolutionize our defense against germ warfare, as well as the treatment of infectious diseases in our population, as a whole. It is possible to include agents which inhibit molecular events leading to septic shock, as well.
"This new technology confers broad spectrum, short term, immunity against unknown biothreat agents for war fighters sent into harm's way."
The study is published in the current issue of the Journal of Allergy & Clinical Immunology.
Copyright 2005 by United Press International
Related stories:
Chemotherapy causes delayed severe neural damage
A commonly used chemotherapy drug causes healthy brain cells to die off long after treatment has ended and may be one of the underlying biological causes of the cognitive side effects – or “chemo brain” – that many cancer patients experience. That is the conclusion of a study published today in the
Journal of Biology.
Eco-Friendly Pyrotechnics
You know it is chemistry when it stinks and goes boom—and entrances us. “No other application in the field of chemistry has such a positive association for the general population as fireworks,” says Thomas Klapötke (University of Munich, Germany).
Snake venoms share similar ingredients
Venoms from different snake families may have many deadly ingredients in common, more than was previously thought. A study published in the online open access journal
BMC Molecular Biology has unexpectedly discovered three-finger toxins in a subspecies of the Massasauga Rattlesnake, as well as evidence for a novel toxin genes resulting from gene fusion.
MicroRNAs may be key to HIV's ability to hide, evade drugs
Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system. Researchers at Jefferson Medical College in Philadelphia have shown that when an individual infected with HIV receives a powerful cocktail of antiviral agents called HAART (highly active antiretroviral therapy), the virus calls on miRNAs to help it remain quiet and practically undetectable, temporarily shutting down its ability to replicate and infect.
U of M researchers discover new method to combat HIV
Researchers at the University of Minnesota’s Center for Drug Design have developed a new method to combat HIV/AIDS, potentially replacing the traditional cocktail drug approach.
Compounds show significant promise against potential bioweapon toxins
Because of the high cost and limited applicability of currently available treatments, the newly identified compounds have the potential to fill the existing therapy gap and to provide protection against a bioterrorism attack using the toxin.
Researchers transform stem cells found in human fat into smooth muscle cells
Researchers from the David Geffen School of Medicine and the Henry Samueli School of Engineering and Applied Science at UCLA today announced they have transformed adult stem cells taken from human adipose – or fat tissue – into smooth muscle cells, which help the normal function of a multitude of organs like the intestine, bladder and arteries. The study may help lead to the use of fat stem cells for smooth muscle tissue engineering and repair.
Measuring the auditory dynamics of selective attention
Call it the cocktail party effect: how an individual can participate in a one-on-one conversation within a cluster of people, switch to another, pick up important comments while tuning out others, change topics and return to the first conversation.